Latest Articles

The desire to understand consciousness is a human need. For some of us, this need presents as a fleeting sense of curiosity every now and then, often becoming buried under the preoccupations of daily life. For others, pursuing this need can become our life's purpose. This is the case for British visual artist Susan Aldworth.

While industrial laboratories can screen vast numbers of potential drug compounds, many academic researchers are adopting more focused strategies.

In this article, we explore the challenges with cryopreservation and the emerging advances that could improve these methods.

In this article, we will explore how advances in genetics and liquid biopsy can be exploited to enhance cancer diagnosis and treatment.

We spoke to Tasnime Osama, honorary clinical research fellow at Imperial College London to learn about the ethical considerations surrounding vaccine passports and how ethical hacking could improve their security.

COVID-19 vaccines are here, they are headed out globally and the world is faced with a giant logistical task: keeping these vaccines in their desired storage conditions to ensure stability and efficacy of every dose that goes into an arm. What are the storage requirements of vaccines and why does it matter?

This article discusses the opportunity to use recent advancements in AI and machine learning for natural product drug discovery.

In this op-ed piece, Michael S. Kinch, director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis, explores the issue of eliminating patent protection for COVID-19 vaccines.

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo nonclinical safety evaluation in animal models. This article explores the full process.

As the pandemic enters its second year, the case for optimism has grown shakier. SARS-CoV-2 has been mutating. New variants have arisen in the United Kingdom, Brazil and South Africa, and seem intent on evading our remarkable new vaccines before we’ve even fully rolled them out.